[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].
The Standards, Options: Recommendations (SOR) project has been undertaken by the French National Federation of Cancer Centers (FNCLCC) is now part of the French National Cancer Institute. The project involves the development and updating of evidence-based Clinical Practice Guidelines (CPG) in oncology. In order to answer questions related to venous thromboembolic events(VTE) treatment and to central venous catheter thrombosis (CVCT) management in cancer patients, the SOR elaborated national guidelines, here presented in a short report. It results of a collaborative work with members from three learned societies("société nationale française de médicine interne": SNFMI, "société française de médicine vasculaire": SFMV and "société française dEanesthésie-réanimation:SFAR).
Mahé
Isabelle
I
Elalamy
Ismail
I
Farge-Bancel
Dominique
D
Mismetti
Patrick
P
Scrobohaci
Marie-Lorraine
ML
Hocini
Hamid
H
Meyer
Guy
G
Kassab-Chahmi
Diana
D
Bosquet
Lise
L
Cajfinger
Francis
F
Desmurs-Clavel
Hélène
H
Desruennes
Eric
E
Douard
Marie-Cécile
MC
Elias
Antoine
A
Grange
Claire
C
Kriegel
Irène
I
Le Gal
Grégoire
G
Lévesque
Hervé
H
Pavic
Michel
M
Renaudin
Jean Marc
JM
Quéré
Isabelle
I
Debourdeau
Philippe
P
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000379:methods; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D051437:Renal Insufficiency / Q000150:complications; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight